ogrel
for patients with stable symptomatic lower extremity arterial disease. Eur J Vasc Endovasc Surg 2021;62:654-5.
140. Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR,
Patel MR, et al. Rivaroxaban in peripheral artery disease after
revascularization. N Engl J Med 2020;382:19